Literature DB >> 12065607

Increased brain histamine levels in Parkinson's disease but not in multiple system atrophy.

J O Rinne1, O V Anichtchik, K S Eriksson, J Kaslin, L Tuomisto, H Kalimo, M Röyttä, P Panula.   

Abstract

We investigated histamine concentration in post-mortem brain samples of patients with Parkinson's disease (PD, n = 24), multiple system atrophy (MSA, n = 8) and age-matched controls (n = 27). Histamine concentrations were significantly increased in the putamen (to 159% of the control mean), substantia nigra pars compacta (to 201%), internal globus pallidus (to 234%) and external globus pallidus (to 200%), i.e. in areas which play a crucial role in the motor behaviour and which show typical functional alterations in PD. In MSA no significant differences were seen. Tele-methylhistamine (histamine metabolite) concentrations were unchanged in PD. These results indicate that histamine concentration, but not its metabolism is increased in PD, but not in MSA. This finding may have implications in developing new drug therapies for PD and in differential diagnosis between PD and MSA.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12065607     DOI: 10.1046/j.1471-4159.2002.00871.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  34 in total

Review 1.  Mechanisms underlying the onset and expression of levodopa-induced dyskinesia and their pharmacological manipulation.

Authors:  Mahmoud M Iravani; Peter Jenner
Journal:  J Neural Transm (Vienna)       Date:  2011-09-01       Impact factor: 3.575

2.  Regional characteristics of histamine uptake into neonatal rat astrocytes.

Authors:  Katja Perdan-Pirkmajer; Sergej Pirkmajer; Andreja Raztresen; Mojca Krzan
Journal:  Neurochem Res       Date:  2013-04-03       Impact factor: 3.996

3.  Histamine Excites Striatal Dopamine D1 and D2 Receptor-Expressing Neurons via Postsynaptic H1 and H2 Receptors.

Authors:  Qian-Xing Zhuang; Han-Ting Xu; Xu-Juan Lu; Bin Li; Wing-Ho Yung; Jian-Jun Wang; Jing-Ning Zhu
Journal:  Mol Neurobiol       Date:  2018-03-01       Impact factor: 5.590

4.  Effect of pre- and postnatal manganese exposure on brain histamine content in a rodent model of Parkinson's disease.

Authors:  Ryszard Brus; Jerzy Jochem; Przemysław Nowak; Marta Adwent; Dariusz Boroń; Halina Brus; Richard M Kostrzewa
Journal:  Neurotox Res       Date:  2011-08-06       Impact factor: 3.911

5.  A Novel Developmental Role for Dopaminergic Signaling to Specify Hypothalamic Neurotransmitter Identity.

Authors:  Yu-Chia Chen; Svetlana Semenova; Stanislav Rozov; Maria Sundvik; Joshua L Bonkowsky; Pertti Panula
Journal:  J Biol Chem       Date:  2016-08-18       Impact factor: 5.157

6.  Determining the Effect of the HNMT, STK39, and NMD3 Polymorphisms on the Incidence of Parkinson's Disease, Amyotrophic Lateral Sclerosis, and Multiple System Atrophy in Chinese Populations.

Authors:  Yongping Chen; Bei Cao; Ruwei Ou; Qianqian Wei; Xueping Chen; Bi Zhao; Ying Wu; Wei Song; Hui-Fang Shang
Journal:  J Mol Neurosci       Date:  2018-03-21       Impact factor: 3.444

Review 7.  International Union of Basic and Clinical Pharmacology. XCVIII. Histamine Receptors.

Authors:  Pertti Panula; Paul L Chazot; Marlon Cowart; Ralf Gutzmer; Rob Leurs; Wai L S Liu; Holger Stark; Robin L Thurmond; Helmut L Haas
Journal:  Pharmacol Rev       Date:  2015-07       Impact factor: 25.468

8.  Histamine is required for H₃ receptor-mediated alcohol reward inhibition, but not for alcohol consumption or stimulation.

Authors:  J Vanhanen; S Nuutinen; M Lintunen; T Mäki; J Rämö; K Karlstedt; P Panula
Journal:  Br J Pharmacol       Date:  2013-09       Impact factor: 8.739

9.  Histaminergic activity in a rodent model of Parkinson's disease.

Authors:  Przemysław Nowak; Lukasz Noras; Jerzy Jochem; Ryszard Szkilnik; Halina Brus; Eva Körossy; Jacek Drab; Richard M Kostrzewa; Ryszard Brus
Journal:  Neurotox Res       Date:  2009-02-28       Impact factor: 3.911

10.  Histamine and deep brain stimulation: the pharmacology of regularizing a brain.

Authors:  Timothy C Whalen; Aryn H Gittis
Journal:  J Clin Invest       Date:  2018-10-29       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.